Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Pakistan Journal of Medicine and DentistryOpen Access

Clinical Spectrum and Treatment Patterns in Patients with Adenoviral Conjunctivitis: A Single Center Experience

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMaeirah ShafiqueNational University of Medical SciencesBSBeenish SaleemArmed Forces Institute of PathologySFSamar FatimaCombined Military Hospital

Discussion

Loading...

Member takes

Overview

Observational study compares treatment effectiveness in 196 patients with adenoviral conjunctivitis, indicating steroids outperform antihistamines.

Key Points

  • Topical corticosteroids showed significant symptom improvement in 68.4% of patients, compared to 46.7% with antihistamines.
  • In total, 196 patients analyzed, with a median age of 31 years and most presenting with redness and discharge.
  • The use of topical steroids resulted in better symptom resolution and fewer ineffective cases, statistically significant with p=0.029.
  • Bilateral eye involvement was observed in 53.6% of patients, emphasizing the need for effective treatment strategies.

Cite This Study

Shafique et al. (2025) studied this question.

synapsesocial.com/papers/68c1a5eb54b1d3bfb60df61dhttps://doi.org/10.36283/ziun-pjmd14-3/046
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A prospective, randomized study comparing different therapeutic modalities for acute adenoviral conjunctivitis2026
  2. 2Conjunctivitis or Camouflage: A Study of Seasonal Variations and Impact of Factors Leading to the Epidemic of Adenoviral Conjunctivitis2026
  3. 3Pattern of Adenoviral Conjunctivitis Reported to Tertiary Care Hospitals During Epidemic in Pakistan2024
  4. 4The 2023 outbreak of viral conjunctivitis: Clinical features and treatment patterns from five states in India2024 · 3 citations
  5. 5EFFICACY OF TOPICAL STEROIDS IN TREATING SEVERE VIRAL CONJUNCTIVITIS: A RANDOMIZED CONTROL TRIAL2024